Editorial
doi: 10.1164/rccm.202004-0896ED.
Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Affiliations
- PMID: 32282222
- PMCID: PMC7427405
- DOI: 10.1164/rccm.202004-0896ED
Item in Clipboard
Editorial
Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Am J Respir Crit Care Med.
.
No abstract available
Comment on
-
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial.Am J Respir Crit Care Med. 2020 Aug 15;202(4):549-557. doi: 10.1164/rccm.201910-2058OC. Am J Respir Crit Care Med. 2020. PMID: 32267724 Free PMC article. Clinical Trial.
Similar articles
-
Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin.Clin Infect Dis. 2010 Jul 15;51(2):143-9. doi: 10.1086/653527. Clin Infect Dis. 2010. PMID: 20536364 Clinical Trial.
-
[Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].Med Mal Infect. 2006 Nov-Dec;36(11-12):706-17. doi: 10.1016/j.medmal.2006.05.011. Epub 2006 Jul 12. Med Mal Infect. 2006. PMID: 16839731 Review. French.
-
Reduced antibiotic pressure for the treatment of acute exacerbation of chronic obstructive pulmonary disease: back to the future.Clin Infect Dis. 2010 Jul 15;51(2):150-2. doi: 10.1086/653528. Clin Infect Dis. 2010. PMID: 20536365 No abstract available.
-
Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?Curr Opin Infect Dis. 2019 Apr;32(2):143-151. doi: 10.1097/QCO.0000000000000533. Curr Opin Infect Dis. 2019. PMID: 30672788 Review.
-
[Antibiotic therapy for acute exacerbations of chronic obstructive pulmonary disease].Internist (Berl). 2011 Jun;52(6):765-7. doi: 10.1007/s00108-011-2863-y. Internist (Berl). 2011. PMID: 21544507 German. No abstract available.
Cited by
-
The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study.Front Pharmacol. 2024 May 10;15:1380939. doi: 10.3389/fphar.2024.1380939. eCollection 2024. Front Pharmacol. 2024. PMID: 38799157 Free PMC article.
-
Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease.Sci Rep. 2023 Oct 7;13(1):16954. doi: 10.1038/s41598-023-44188-2. Sci Rep. 2023. PMID: 37805617 Free PMC article.
References
-
- Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, Murphy TF. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:491–497. - PubMed
-
- Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Müllerova H, Donaldson GC, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29:527–534. - PubMed
-
- Ritchie AI, Brill SE, Vlies BH, Finney LJ, Allinson JP, Alves-Moreira L, et al. Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin: a double-blind, randomized, placebo-controlled, multicenter, phase III clinical trial. Am J Respir Crit Care Med. 2020;202:549–557. - PMC - PubMed
-
- Jacobs DM, Pandit U, Sethi S. Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones? Curr Opin Infect Dis. 2019;32:143–151. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
